Education: Doctor of Pharmacy, Rutgers University (2012); PhD, Brown University School of Public Health, 2017; Master of Science, Epidemiology, Brown University School of Public Health (2015)
Professional Memberships: International Society for Pharmacoepidemiology (ISPE), Society for Epidemiologic Research (SER), AcademyHealth, American Society of Health System Pharmacists (ASHP)
Practice/Research Interests: Pharmacoepidemiology, Pharmaceutical Importation, Geriatrics/Aging, Nursing Homes, Comparative Effectiveness Research, Patient-Centered Outcomes Research, Causal Inference, Conditional Economic Incentives.
Rotation Offered: Outcomes Research and Healthcare Analytics
Andrew Zullo, PharmD, RPh, is a pharmacoepidemiologist and health services researcher. His primary research interest is the study of prescription drug effects, especially drug safety and comparative effectiveness research. His secondary research interest is pharmaceutical policy, including prescription drug importation and economic interventions to improve prescription drug adherence. He has used complex survey data and health plan claims data that have been supplemented through data linkages. His methodological expertise covers topics related to studying medical interventions in the setting of non-randomized treatment groups and incomplete data. His clinical areas of interest are diabetes mellitus, HIV and aging. Zullo serves as a mentor to trainees through the Brown University Center for Gerontology and Healthcare Research, Brown University Sheridan Center for Teaching and Learning, and Rhode Island Hospital.